Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Evaluation of lesion network mapping as a technique to identify therapeutic targets for brain disorders

Project description

Targeted brain stimulation for cervical dystonia treatment

Brain disorders are a leading cause of disability, placing a heavy burden on individuals and society. Current treatments are invasive, non-specific, and may result in harmful side effects. Non-invasive methods like repetitive transcranial magnetic stimulation (rTMS) have emerged as alternatives, but their application across various disorders has been slow. This is due, in part, to the difficulty in pinpointing the exact areas of the brain that require stimulation. Supported by the Marie Skłodowska-Curie Actions programme, the NetworkStim project will test whether rTMS can effectively treat cervical dystonia using lesion network mapping (LNM) to identify the optimal stimulation site. The study will use a randomised, sham-controlled, double-blind trial involving 30 patients to assess the therapeutic potential of rTMS.

Objective

Disorders of the brain are a major source of disability, and place an enormous burden on society. Currently, many first-line treatments
are non-specific, invasive, or cause side-effects. Non-invasive brain stimulation techniques, such as repetitive transcranial magnetic
stimulation (rTMS), have been shown to offer a safe treatment alternative, with rTMS first clinically approved for major depression in 2007. Unfortunately since then, translation to other disorders has been slow, mainly due to the lack of reliable methods to identify where in the brain to stimulate. Lesion network mapping (LNM) is a method recently introduced to address this problem. LNM works by mapping the connections of causative brain lesions, converging upon a small number of commonly connected locations in the brain. LNM has localised abnormal networks in over 40 different disorders. However, as yet no study has tested whether these networks respond to treatment. Therefore, the aim of this study is to conduct a clinical trial testing whether rTMS delivered to a specific site in the somatosensory cortex identified in our previously published LNM study (Corp et al., 2019, Brain) results in treatment benefit for cervical dystonia patients. Cervical dystonia is an ideal test case, as changes in abnormal neck movement symptoms are easily measurable, and this somatosensory location is on the surface of the brain, so easily reachable with rTMS. We will employ a randomised, sham-controlled, double-blind, crossover clinical trial, with 30 patients receiving 10 daily sessions of real and sham rTMS. Before and after the brain stimulation, we will collect clinical, behavioural, and physiological data to measure patients’ response to the intervention. Improvement in cervical dystonia symptoms after brain stimulation would serve as proof of the principle that LNM can effectively identify therapeutic targets, potentially unlocking safe and effective treatment protocols for a range of brain disorders.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2023-PF-01

See all projects funded under this call

Coordinator

FONDAZIONE POLICLINICO UNIVERSITARIO CAMPUS BIO MEDICO
Net EU contribution
€ 158 354,24
Address
VIA ALVARO DEL PORTILLO 200
00128 ROMA
Italy
Region
Centro (IT) Lazio Roma
Activity type
Research Organisations
Links
Total cost
No data

Partners (1)